Rituximab Treatment Efficacy in Patients With Systemic Lupus Erythematosus Refractory to Standard Therapy in the Long-Term Follow-Up

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2014-159-168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus

Turkish Journal of Haematology
Hematology
2012English

Serial Follow Up of Soluble Thrombomodulin Levels in Patients With Systemic Lupus Erythematosus

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2000English

Efficacy of Rituximab (Anti-Cd20) for Refractory Systemic Lupus Erythematosus Involving the Central Nervous System

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

Rituximab in the Treatment of Extensive and Refractory Subacute Cutaneous Lupus Erythematosus

Anais Brasileiros de Dermatologia
Dermatology
2018English

Anti-B Cell Therapy in Patients With Systemic Lupus Erythematosus

Modern Rheumatology Journal
2017English

Resilience and Treatment Adhesion in Patients With Systemic Lupus Erythematosus

Open Rheumatology Journal
Rheumatology
2014English

Experience of Long-Term Belimumab Use in Patients With Systemic Lupus Erythematosus (A Case Report)

Modern Rheumatology Journal
2013English

Effects of Treatment With Rituximab on Microcirculation in Patients With Long-Term Systemic Sclerosis

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

Tuberculosis in Patients With Systemic Lupus Erythematosus.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy